Condensed Consolidated Statements of Operations (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Revenue
Product sales	$ 400,000	$ 290,042	$ 937,080	$ 426,142
Cost of product sales	247,184	119,939	415,550	185,132
Gross profit from product sales	152,816	170,103	521,530	241,010
Other Revenue
Retained royalties	19,781	22,332	24,733	40,092
Other income	14,204	14,499	31,677	72,821
Total other revenue	33,985	36,831	56,410	112,913
Expenses
Selling expenses	38,470	22,569	176,496	126,502
Personnel and consulting expenses	296,944	219,379	1,116,088	839,118
General and administrative expenses	432,528	450,272	943,554	1,264,448
Interest expense	574,840	67,058	792,520	143,796
Interest expense - accelerated upon conversion of OID notes			35,109
Loss on conversion of notes	5,500		48,788
Loss on settlement of note and warrant			132,301
Unrealized loss on derivative instruments	67,631	49,865	79,351	41,137
Total Expenses	1,415,913	809,143	3,324,207	2,415,001
Loss before income taxes	(1,229,112)	(602,209)	(2,746,267)	(2,061,078)
Provision (benefit) for income taxes
Net loss	$ (1,229,112)	$ (602,209)	$ (2,746,267)	$ (2,061,078)
Basic and diluted loss per share	$ (0.05)	$ (0.04)	$ (0.12)	$ (0.13)
Basic and diluted weighted average number of common shares outstanding:	24,974,613	16,867,971	22,715,940	16,205,578